Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Dec 15, 2025

Zebrafish Model of Neuroblastoma Metastasis
05:20

Zebrafish Model of Neuroblastoma Metastasis

Published on: March 14, 2021

3.1K

Modeling oncolytic virus dynamics in the tumor microenvironment using zebrafish.

David Mealiea1,2,3, Emilie Boudreau4, Naomi De Silva4

  • 1Department of Surgery, University of Toronto, Toronto, Ontario, Canada. d.mealiea@mail.utoronto.ca.

Cancer Gene Therapy
|July 11, 2020
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ERG preserves endothelial identity to limit atherosclerosis.

Nature communications·2026
Same author

REPLY: Refining Vascular Biomarker-Guided Risk Stratification for Cancer Therapy-Related Cardiac Dysfunction.

JACC. CardioOncology·2026
Same author

"We're Kind of in This Weird Space": How Asian Americans physicians navigate perspectives towards race-conscious admissions.

Medical education·2026
Same author

ERG is a regulator of dynamic and reversible endothelial plasticity.

Genome medicine·2026
Same author

Language Matters: Integrating Community Voices into the University of Utah Quick Language Guide.

Teaching and learning in medicine·2026
Same author

Methodology and Past Topics for the 2025 CERA Department Chair Survey.

PRiMER (Leawood, Kan.)·2026

Researchers developed a zebrafish tumor xenograft model for oncolytic virotherapy. This inexpensive, real-time model shows measurable antitumor effects and aids in studying virotherapy

Area of Science:

  • Oncolytic Virotherapy
  • Cancer Research
  • Zebrafish Models

Background:

  • Oncolytic virotherapy utilizes viruses to selectively target and destroy cancer cells.
  • Developing effective and accessible preclinical models is crucial for advancing virotherapy research.
  • Existing models may lack the biological fidelity or cost-effectiveness for comprehensive virotherapy studies.

Purpose of the Study:

  • To adapt and validate a zebrafish (Danio rerio) tumor xenograft model for studying oncolytic virotherapy.
  • To demonstrate the model's capability for real-time, in vivo investigation of virotherapy dynamics.
  • To establish a cost-effective platform for evaluating novel oncolytic viruses and combination therapies.

Main Methods:

  • Mammalian cancer cells were xenografted into zebrafish embryos (48 hours post-fertilization).

More Related Videos

Generation of Zebrafish Larval Xenografts and Tumor Behavior Analysis
12:08

Generation of Zebrafish Larval Xenografts and Tumor Behavior Analysis

Published on: June 19, 2021

13.6K
In Vivo Imaging and Quantitation of the Host Angiogenic Response in Zebrafish Tumor Xenografts
11:07

In Vivo Imaging and Quantitation of the Host Angiogenic Response in Zebrafish Tumor Xenografts

Published on: August 14, 2019

7.3K

Related Experiment Videos

Last Updated: Dec 15, 2025

Zebrafish Model of Neuroblastoma Metastasis
05:20

Zebrafish Model of Neuroblastoma Metastasis

Published on: March 14, 2021

3.1K
Generation of Zebrafish Larval Xenografts and Tumor Behavior Analysis
12:08

Generation of Zebrafish Larval Xenografts and Tumor Behavior Analysis

Published on: June 19, 2021

13.6K
In Vivo Imaging and Quantitation of the Host Angiogenic Response in Zebrafish Tumor Xenografts
11:07

In Vivo Imaging and Quantitation of the Host Angiogenic Response in Zebrafish Tumor Xenografts

Published on: August 14, 2019

7.3K
  • Oncolytic virus treatment was administered 24 hours post-tumor cell injection.
  • Confocal fluorescent imaging was employed to quantify tumor microenvironment dynamics.

    • Main Results:

    • The zebrafish model demonstrated tumor-specific infection and measurable antitumor effects following oncolytic virus treatment.
    • The model allows for real-time, in vivo visualization of tumor and immune cell interactions during virotherapy.
    • The system exhibits biological fidelity to human cancer development processes relevant to virotherapy efficacy.

    Conclusions:

    • The adapted zebrafish xenograft model is a powerful and inexpensive tool for oncolytic virotherapy research.
    • This model facilitates the evaluation of novel oncolytic viruses and combination therapies.
    • It offers potential for investigating the impact of virotherapy on immune response, tumor vasculature, and metastasis.